Law Firm Initiates Securities Investigation Into Beta Bionics Following Sharp Stock Decline
Law firm investigates Beta Bionics for potential securities fraud after stock plunged 37% due to slowing patient growth, missing investor expectations on guidance accuracy.
NAVNBBNXCVRXsecurities fraudclass action lawsuit